A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures
Publication type: Journal Article
Publication date: 2021-04-01
SJR: —
CiteScore: —
Impact factor: —
ISSN: 09284931, 18730191
PubMed ID:
33812619
Bioengineering
Biomaterials
Mechanics of Materials
Abstract
A number of clinical studies have highlighted the success of antibiotics formulated at concentrations between 0 and 6% w /w into bone cements to address localized infections. Separately, some commercial manufacturers have produced gentamycin-infused bone cement mixtures as a countermeasure to infection. The anecdotal evidence suggests that antibiotic infused cements can help eradicate or delay the onset of infections. Quantifying the functionality of that response is more challenging. We have surveyed the literature to identify studies in which controlled drug release or mechanical behavioral assessments have been conducted on drug-infused cements. The focus here is on vancomycin (VAN) in part due to its higher potency relative to gentamycin and its more common usage for staph infections. Takeaways from the limited pool of research studies indicate that large fractions (>99%) of the infused vancomycin remain sequestered in the cement and aren't bioavailable after solidification. Antibiotic fluence ranged from 1 to 283 μg/cm 2 hr. The initial strength of the various antibiotic loaded samples as produced were 52–96 MPa. Simulated exposures in a fluid environment by submersion reduced the antibiotic loaded strengths between 3 and 29%. Some strength measurements were noted below the ASTM F451 standard for acrylic bone cement although drug releasing spacers likely have different requirements. The glassy behavior of the cured cement led to both vancomycin and gentamicin having low permeability and a burst response. Smaller drug molecules and more gel-like immobilization matrices with lower glass transition temperatures offer higher potential for larger and more comprehensive drug bioavailability. • ALBCs release antibiotic as a small but clinically effective burst dose. • More loading is linked with higher dose and weaker cement strength. • Future antibiotic release systems will use both diffusion and burst release schemes.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Chemical Engineering Journal
2 publications, 10.53%
|
|
|
Genij Ortopedii
2 publications, 10.53%
|
|
|
JAAOS Global Research and Reviews
1 publication, 5.26%
|
|
|
World Journal of Orthopaedics
1 publication, 5.26%
|
|
|
Nanomaterials
1 publication, 5.26%
|
|
|
Knee
1 publication, 5.26%
|
|
|
Polymers
1 publication, 5.26%
|
|
|
Pharmaceutics
1 publication, 5.26%
|
|
|
N N Priorov Journal of Traumatology and Orthopedics
1 publication, 5.26%
|
|
|
Composites - Part A: Applied Science and Manufacturing
1 publication, 5.26%
|
|
|
Traumatology and Orthopedics of Russia
1 publication, 5.26%
|
|
|
Arthroplasty Today
1 publication, 5.26%
|
|
|
Open Forum Infectious Diseases
1 publication, 5.26%
|
|
|
AAPS PharmSciTech
1 publication, 5.26%
|
|
|
Applied Biochemistry and Microbiology
1 publication, 5.26%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
Elsevier
5 publications, 26.32%
|
|
|
MDPI
3 publications, 15.79%
|
|
|
Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics
2 publications, 10.53%
|
|
|
Eco-Vector LLC
2 publications, 10.53%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 5.26%
|
|
|
Baishideng Publishing Group
1 publication, 5.26%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 5.26%
|
|
|
Oxford University Press
1 publication, 5.26%
|
|
|
Springer Nature
1 publication, 5.26%
|
|
|
Pleiades Publishing
1 publication, 5.26%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
19
Total citations:
19
Citations from 2024:
14
(73.69%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Mensah L. M., Love B. J. A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures // Materials Science and Engineering C. 2021. Vol. 123. p. 111999.
GOST all authors (up to 50)
Copy
Mensah L. M., Love B. J. A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures // Materials Science and Engineering C. 2021. Vol. 123. p. 111999.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.msec.2021.111999
UR - https://doi.org/10.1016/j.msec.2021.111999
TI - A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures
T2 - Materials Science and Engineering C
AU - Mensah, Lydia M
AU - Love, Brian J
PY - 2021
DA - 2021/04/01
PB - Elsevier
SP - 111999
VL - 123
PMID - 33812619
SN - 0928-4931
SN - 1873-0191
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Mensah,
author = {Lydia M Mensah and Brian J Love},
title = {A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures},
journal = {Materials Science and Engineering C},
year = {2021},
volume = {123},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.msec.2021.111999},
pages = {111999},
doi = {10.1016/j.msec.2021.111999}
}